FDA Adverse Event Injury Summary report: N

INTEGRITY RX

MDR report key: 2944909 · Received February 6, 2013

Report

Report Number
9612164-2013-00123
Event Type
Injury
Date Received
February 6, 2013
Date of Event
December 19, 2012
Report Date
January 31, 2014
Manufacturer
MEDTRONIC IRELAND
Product Code
MAF
PMA / PMN Number
P030009
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4): EVALUATION, RESULTS: INHERENT RISK OF PROCEDURE (RESTENOSIS).

Additional Manufacturer Narrative · 1

(B)(4)

Description of Event or Problem · 1

PATIENT HAD AN INTEGRITY RAPID EXCHANGE (RX) CORONARY STENT IMPLANTED IN THE RCA. APPROXIMATELY 28 MONTHS POST PROCEDURE THE PATIENT UNDERWENT A REVASCULARIZATION OF THE RCA. PATIENT HAD A NON-MEDTRONIC STENT IMPLANTED. APPROXIMATELY 5 MONTHSLATER THE PATIENT UNDERWENT ANOTHER REVASCULARIZATION OF THE RCA. PATIENT HAD A NON-MEDTRONIC STENT IMPLANTED.

Description of Event or Problem · 1

THE PREVIOUSLY REPORTED TVR EVENT OCCURRED APPROXIMATELY 3 MONTHS POST INTEGRITY STENT IMPLANT NOT 28 MONTHS AS PREVIOUSLY REPORTED. APPROXIMATELY 13 MONTHS POST INTEGRITY STENT IMPLANT A REVASCULARIZATION OF THE RCA WAS CARRIED OUR WHERE AN INTEGRITY STENT WAS IMPLANTED. THE EVENT WAS NOT ASSESSED FOR RELATEDNESS. PATIENT RECOVERED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
50451 INTEGRITY RX STENT, CORONARY MAF MEDTRONIC IRELAND

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention ASPIRIN, CLOPIDOGREL